Member Info for Toyin

thomas, it isn’t price sensitive. Just because we have launched doesn’t mean we have any sales that are news worthy.

Bel, we have launched in Spain, Italy following shortly. I’m sure there will be promotional offers in both countries and other countries we launch into. A lot can happen in the coming months, but there is no way they will stop producing AxisBiotix. Irrespective of whether it’s a MN or distribution deals, someone will take it, it’s an excellent product. Management are just trying to get the best long term deal for all concerned.

The MN’s want multiple products, the whole pillar, why would we stop producing our first product, plus we will have acne very soon. We are also in negotiations to buy a company which will give us the ability to deliver those multiple products a lot quicker as they already have topical creams for acne, eczema and psoriasis which we can back our ip into. Obviously they need to land the deal, I think the near term future is bright, but if you want to take your ball home go for it.

Ah, Oleric the professional cynic wishes for others to supply him with more research with no cost in time to himself. I’m afraid I’m going with Clio on this one, you want it, go and find it, it’s out there.

bel, I don’t think our lysate will replace Matrixyl, I think it will go in all new, next generation products. I do believe it is superior because it is scientifically validated, so will sit above Matrixyl.

I know the link below is five years old but you get the idea. For eg L’Oréal own more than 30 brands, so if L’Oréal is one of the VIP’s, you aren’t getting one customer, you are getting 30.

https://www.insider.com/companies-beauty-brands-connected-2017-5

Aquae, you are correct, hence the 12 VIP’s receiving the lysate from the 600 litre vessel so they could test in their own products. Croda produce the lysate and I’m sure they will have different formulations for day creams, night creams, sun creams, etc, etc, they will then sell that ingredient on to their customers who will then blend it into their own products.

oleric, you know my thoughts. Bel is wrong, we have a dedicated production line for the lysate, the end. Bel thinks that is horse ****, I think he’s talking horse ****.

Plus, I can’t believe this hasn’t been discussed, the lysate isn’t the be-all and end-all.

Q: SkinBiotix/Lysate – I believe Croda can use both the lysate and the SkinBiotix platform. What can you share in this regard?
Stuart: I must be very careful with my answer because this is a legal minefield.
Q: OK, fine, but is my understanding correct?
Stuart: You are correct; Croda has access to our SkinBiotix platform and a license to manufacture our lysate. I cannot go into detail about how Croda uses our technology platform. I am not allowed to discuss this. But, look, the conversation and feedback are clear; the anti-ageing lysate is not the be-all and end-all; this is just the beginning of a multi-channel/product journey that has only just started.
Q: Do we know if they use the lysate or the tech platform to develop their ingredients?
Stuart: Croda are manufacturing our lysate as per the license agreement, and yes, they can use our technology to develop ingredients, but I can not add further to this at this stage. So, the same response.

Oleric, for the love of god! Axisbiotix is nothing to do with Croda, nothing, nada, zip, square root of Jack! Nothing!!! Have you done one jot of research?

My posts are for BB members who like open intellectual discussion examining both negative and positives so others please look away. But they also have to have a bit of bloody research, your ignorance is offensive!

Bel, the facts are:

1, Croda have built a “dedicated” production line at a cost of circ €5m.

2. They have scaled up to 20,000 litres.

Aquae makes a very good point, why build a 20,000 litre vessel unless it was needed. Why not 5000 or 10000? I would guess they have done some calculations and decided this is what they need, just a thought!

We probably have 5% of the information available but the facts are the facts, irrespective of your “expertise” in this sector. To call it “horse****” is, well “horse****”j

So bel, if it’s “horse ****” I would like to know who you think is lying, is it Stuart or is it Croda? Please watch from 14m 20sec.

https://www.skinbiotherapeutics.com/stuart-ashman-presenting-at-the-share-profits-virtual-show-on-saturday-9th-may-2020/

Aquae, I don’t believe there will. They have plenty of options, use a combination of cash (already raised) raise debt against the profitable company being acquired, issue some paper, earn out, there is more than one way to pay for it. Just my pennies worth.

anon, it the acquisition doesn’t land. I would suggest we have £1m left plus the £2.5m, I would guess that would last circa 18 months. (Not including anything from Croda etc)

If the acquisition does land, I would suggest the board has raised enough to see us through as the target is profitable, I would say they have run their numbers on synergies etc and will structure the deal to get us through to break even, no more fund raise.

You then rant about fanboys and this share is a POS. You are entitled to your opinion, but I would say if those are your feelings irrespective of being down 75% I would sell, because if you feel it is a POS, to hold is illogical.

Am I happy with the share price, no, I would guess the board aren’t happy either. Have mistakes been made, yes, putting out the £1.2m. But this was based on information at the time, as things progressed the board decided this was not the best route and decided to change course. Has Croda slipped, maybe a tad, but I think it’s because of the enhancements they found and they needed to re-evaluate, if it was something negative it would have to be rns’d. I personally see plenty of upside and am happy to hold. I believe Q1 will be very interesting, in a good way, I certainly won’t be selling, quite the opposite.

I suggest over the holidays you read, “The art of execution” by Lee Freeman-Shor. By the sounds of it you are doing the the exact opposite of what a successful investor does.

Merry Christmas everyone.

Ody, you really are a weapon. I know you have refused to answer my first question, so I shall leave you with this. You say:

"£1.8m in cash left and losing about £3mill a year.... so what? 7/8 months cash left? A dilution in Q1 2023?

They have just raised just over £2.5m you tool!

Ody, no, it is not. You could not be more wrong.

The question still stands, how does axis sales affect the Croda negotiations?

I agree bel, it's not a straight game. Unfortunately this is the world we live in.

Belgrano, for the last time. One of the distribution deals i.e. the U.S. was tied to the NPF and because SA didn't sign the U.S. distribution deal we lost access to the NPF sales and subscriptions. There is nothing sinister in it, SA decided it wasn't right and turned it down, because of length of agreement and margin surrender. Can you imagine if he signed the £1.2m and then in six months said, (this is an example) "oh by the way our net from that is £300,000 because we got spanked on the margin, also we are locked in for another four years!" Please watch at 26m 21sec.

https://youtu.be/eZsW0tVnpCs?t=1581

Belgrano, The derma company we are hopefully acquiring has many synergies as SA has alluded to, we wont know the full plan until it is announced. I think there is way too much focus on Psoriasis. The preregistration where lost because they where linked to the NPF and because the distribution deals weren't signed we lost that opportunity, I believe that was the right decision as they were minimum 5 years and significant margin surrender.

As for the MN's, there is no way the nomad would let SA put that in rns's and keep mentioning them in interviews if it wasn't true, irrespective of what your friends think. These things take time, they dont want just psoriasis, they want the whole pillar, multiple products, powders, chewing gum, creams, etc, etc. If he can pull this acquisition off I think its a game changer.

I suggest you watch the proactive interview from the 16th and read the Q&A Elric did the other day and read it properly.

Ody, why do you keep bringing Axis sales into it, they have no bearing on the Croda discussions? Its a completely separate pillar.

Fair play to TW for posting it. It was a very good interview and needs reading by as many as possible. Well done Elric!

Ody, do you want to answer my question on the voted thread?

Ody, lets take this one step at a time. you say:

"And then you agree that sales are not significantly increasing. so if i was croda and still wanted this, i would say "reduce your cist by X % amount or we wont buy and we will leave your product to wither and die just like opti".

My "sales not significantly increasing" comment was in relation to the Axis sales, nothing to do with Croda.

My question, what do you mean when you say, "reduce your cist by X % amount or we wont buy and we will leave your product to wither and die just like opti"?